HK1 and acute myeloid leukemia: Hexokinase 3: HK3 is upregulated in several cancers, including acute myeloid leukemia (AML), where it plays the role of an anti-apoptotic protein to promote tumor cell survival alongside HK1 and 2 [130,131].